+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

ACVR1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ACVR1 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
IgE Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

IgE Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Apolipoprotein C-III Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Apolipoprotein C-III Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
NLRP3 Protein Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

NLRP3 Protein Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
From
Alpha4beta7 Integrin Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha4beta7 Integrin Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
MALT1 Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

MALT1 Protein Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
MCL1 Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

MCL1 Protein Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin 8 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 8 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ATR Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ATR Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Factor XI Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Factor XI Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Viral Core Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Viral Core Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neonatal Fc Receptor Antagonists- Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Fc Receptor Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement C1s Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1s Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-12 Expression Stimulants - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-12 Expression Stimulants - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement C3 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C3 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more